Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant
SARS-CoV-2 Beta and Omicron variants have multiple mutations in the receptor-binding domain (RBD) allowing antibody evasion. Despite the resistance to circulating antibodies in those who received two doses of mRNA vaccine, the third dose prominently recalls cross-neutralizing antibodies with expande...
Saved in:
Published in | bioRxiv |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Paper |
Language | Japanese |
Published |
Cold Spring Harbor Laboratory
26.12.2021
|
Edition | 1.1 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!